$116 M

BENH Mkt cap, 22-Sept-2020
Bio-En Holdings Net income (Q2, 2020)-15.6 K
Bio-En Holdings EBIT (Q2, 2020)-15.6 K
Bio-En Holdings Cash, 30-Jun-2020270
Bio-En Holdings EV116.4 M

Bio-En Holdings Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

Sales and marketing expense

9.6k

General and administrative expense

226.7k

Operating expense total

405.0226.7k9.6k

Depreciation and amortization

19.4k19.4k

EBIT

(88.4k)(126.2k)

Interest expense

4.8k6.8k

Pre tax profit

(226.7k)(220.0k)

Net Income

(37.9k)(226.7k)(220.0k)(195.6k)308.7k(88.4k)(126.2k)

Quarterly

USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

General and administrative expense

58.9k48.1k

Operating expense total

25.0121.0256.0298.058.9k48.1k

Depreciation and amortization

4.8k4.8k

EBIT

19.8k(32.2k)(15.0k)(19.6k)(15.6k)

Interest expense

2.7k240.0

Pre tax profit

48.1k(50.6k)

Net Income

(10.0k)(3.2k)(10.2k)(11.0k)(9.7k)(58.9k)(48.1k)(47.9k)(63.6k)(55.0k)(44.6k)(42.1k)(42.9k)(16.3k)(13.4k)(32.2k)(15.0k)(19.6k)(254.4k)(15.6k)

Bio-En Holdings Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

32.6k1.5k1.3k1.1k60.05.4k420.0

Accounts Receivable

6.2k241.1k

Prepaid Expenses

589.0

Current Assets

1.5k1.3k1.1k60.011.6k241.5k

Total Assets

33.2k266.4k246.8k227.2k60.011.6k241.5k

Accounts Payable

13.1k135.8k194.0k139.5k37.4k49.0k

Short-term debt

34.4k380.3k

Current Liabilities

289.7k465.7k209.5k73.2k429.3k

Total Debt

34.4k380.3k

Total Liabilities

13.7k569.3k745.3k209.5k73.2k429.3k

Common Stock

149.03.2k3.2k7.7k7.7k

Preferred Stock

Additional Paid-in Capital

57.9k120.9k120.9k120.9k120.9k352.7k352.7k

Retained Earnings

(226.7k)(446.7k)(642.3k)(333.6k)(422.0k)(548.1k)

Total Equity

19.5k(102.5k)(322.5k)(518.1k)(209.4k)(61.6k)(187.7k)

Financial Leverage

1.7 x-2.6 x-0.8 x-0.4 x0 x-0.2 x-1.3 x

Quarterly

USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

20.0k6.9k33.2k9.2k1.6k1.4k1.4k1.3k1.3k1.2k1.2k1.1k1.1k1.0k18.019.0k4.8k4.7k4.7k345.0270.0

Accounts Receivable

589.0500.026.8k5.7k5.7k5.7k5.7k6.4k5.2k

Prepaid Expenses

1.5k

Current Assets

1.4k1.4k1.3k1.3k1.2k3.2k1.1k1.1k1.0k518.026.8k24.7k10.6k10.4k10.4k6.8k5.5k

Total Assets

20.0k6.9k34.7k9.8k1.6k261.5k256.6k251.7k241.9k237.0k234.2k222.3k217.5k212.6k518.026.8k24.7k10.6k10.4k10.4k6.8k5.5k

Accounts Payable

10.0k654.04.2k40.0k74.0k90.5k96.8k152.5k174.2k189.4k207.6k211.7k219.3k19.7k24.0k18.4k38.1k52.9k35.4k63.7k71.9k

Short-term debt

19.9k24.7k29.6k39.2k44.1k48.9k58.7k(63.5k)68.3k385.1k391.3k

Current Liabilities

335.3k385.4k427.1k503.5k540.2k578.4k19.7k36.0k47.3k104.4k119.2k149.3k448.9k463.1k

Total Debt

19.9k24.7k29.6k39.2k44.1k48.9k58.7k(63.5k)68.3k385.1k391.3k

Total Liabilities

10.6k593.0593.01.2k10.3k47.8k412.1k455.1k513.8k615.0k665.1k706.8k783.2k819.9k858.0k19.7k36.0k47.3k104.4k119.2k149.3k448.9k463.1k

Common Stock

125.0125.0149.0939.0939.03.2k3.2k3.2k3.2k3.2k3.2k3.2k3.2k3.2k7.2k7.7k7.7k7.7k7.7k7.7k7.7k7.7k

Preferred Stock

Additional Paid-in Capital

19.9k19.9k57.9k57.1k47.9k120.9k120.9k120.9k120.9k120.9k120.9k120.9k120.9k120.9k326.9k352.7k352.7k352.7k352.7k352.7k352.7k352.7k

Retained Earnings

(172.4k)(274.8k)(322.7k)(386.2k)(497.2k)(552.2k)(596.8k)(685.0k)(726.6k)(769.6k)(353.4k)(369.6k)(383.0k)(454.2k)(469.2k)(499.3k)(802.5k)(818.1k)

Total Equity

9.4k6.3k34.1k8.6k(10.3k)(46.3k)(150.6k)(198.5k)(262.1k)(373.1k)(428.1k)(472.6k)(560.8k)(602.4k)(645.4k)(19.2k)(9.2k)(22.6k)(93.8k)(108.8k)(138.9k)(442.1k)(457.7k)

Financial Leverage

2.1 x1.1 x1 x1.1 x0 x-1.7 x-1.3 x-1 x-0.6 x-0.6 x-0.5 x-0.4 x-0.4 x-0.3 x0 x-2.9 x-1.1 x-0.1 x-0.1 x-0.1 x0 x0 x

Bio-En Holdings Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(37.9k)(226.7k)(220.0k)(195.6k)308.7k(88.4k)(126.2k)

Depreciation and Amortization

15.0k19.4k19.4k

Accounts Receivable

(589.0)(6.2k)(234.9k)

Accounts Payable

13.1k47.2k82.4k58.2k(54.5k)(102.1k)11.6k

Cash From Operating Activities

(25.4k)(20.8k)(28.2k)(28.0k)13.1k(196.7k)(349.4k)

Cash From Investing Activities

Cash From Financing Activities

58.0k22.3k28.0k27.8k(14.2k)344.4k

Net Change in Cash

32.6k1.5k(194.0)(168.0)(1.1k)5.4k(5.0k)

Bio-En Holdings Ratios

USDQ1, 2013

Financial Leverage

2.1 x